Insight into structure of HIV protein may help design drugsJune 10th, 2010 - 4:37 pm ICT by ANI
London, June 10 (ANI): Scientists have created a three-dimensional picture of an important protein that is involved in how HIV — the virus responsible for AIDS — is produced inside human cells.
The picture may help in the development of drugs to prevent HIV from reproducing.
The research team, led by David Price, UI professor of biochemistry, and Tahir Tahirov, professor of structural biology at the Eppley Institute at the University of Iowa Carver College of Medicine and University of Nebraska Medical Center (UNMC), combined expertise in protein chemistry and X-ray crystallography — a technique for observing protein structures — to produce the first crystal structure of the HIV protein called Tat.
The structure shows Tat attached to the human protein (P-TEFb) that the virus hijacks during infection.
The structure shows how Tat latches on to this particular human protein and how the interaction alters the shape of the human protein.
“We have solved the long sought-after structure of an important HIV protein. Now that we know the details of the interaction between Tat and P-TEFb, it may be possible to design inhibitors that target P-TEFb only when it is interacting with Tat,” Price said.
This distinction is important because although inhibiting P-TEFb blocks replication of the HIV virus, P-TEFb is a vital protein in human cells and inhibiting it kills cells. If an inhibitor could be designed that distinguishes between the P-TEFb attached to Tat and the form that is normal in human cells, that drug might target HIV replication without harming normal cell function.
Such compounds could be useful in combination with existing anti-HIV drugs to further reduce viral levels in HIV-infected individuals.
In addition, drugs that target P-TEFb may also be useful in treating drug-resistant HIV, which is a growing problem. The HIV virus mutates very easily and can develop resistance to current drug that target viral proteins. Targeting a human protein like P-TEFb that the virus needs but cannot mutate may be a successful strategy to counter drug-resistant HIV.
The study has been published in the June 10 issue of the journal Nature. (ANI)
- Cancer drug successfully purges hidden HIV virus - Mar 09, 2012
- 1 drug, many targets may be the future of healing! - Apr 29, 2011
- How HIV reactivates after entering a dormant state - Feb 27, 2011
- Molecule engineered to attack HIV shows positive results - Jan 20, 2011
- How 'chameleon-like' HIV virus eludes treatment by mutating - Dec 16, 2010
- Triple-punch gene therapy offers hope to AIDS patients - Jun 17, 2010
- Molecular changes that helped Tamiflu resistance explained - Jun 04, 2010
- Measles virus is 'the latest weapon against cancer' - Jan 13, 2011
- New compound destroys deadly flu virus - Sep 26, 2011
- Viral protein structure could strengthen HIV therapy - Jun 23, 2010
- Gold nanorods may help attack H1N1, other flu viruses effectively - May 25, 2010
- Study offers potential new targets for novel anti-HIV drugs - Mar 26, 2011
- How HIV resists AIDS preventing AZT drug - Sep 20, 2010
- Target to inhibit HIV infectivity identified - Jan 05, 2010
- How H1N1 virus infects body - Dec 22, 2009
Tags: carver college, design drugs, drug resistant hiv, eppley institute, first crystal, hiv drugs, hiv protein, hiv replication, hiv virus, human cells, human protein, nebraska medical center, protein chemistry, protein structures, structure of hiv, ui professor, university of nebraska medical center, viral levels, viral proteins, x ray crystallography